About Foresee Biosystems
Foresee Biosystems is a company based in Genoa (Italy) founded in 2021 by Michele Dipalo. Foresee Biosystems offers products and services including IntraCell. Foresee Biosystems operates in a competitive market with competitors including Altis Biosystems, Toxys, ATANIS Biotech, Inovotion and ABL Diagnostics, among others.
- Headquarter Genoa, Italy
- Founders Michele Dipalo
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Foresee Biosystems Srl
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$868.91 K (USD), Grant
Apr 01, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Foresee Biosystems
Foresee Biosystems offers a comprehensive portfolio of products and services, including IntraCell.
Enables recordings of action potentials from cardiomyocytes for toxicity prediction.
Funding Insights of Foresee Biosystems
Investors in Foresee Biosystems
Foresee Biosystems has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Foresee Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Foresee Biosystems
Investment portfolio details for Foresee Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Foresee Biosystems
Detailed financials for Foresee Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Foresee Biosystems Comparisons
Peer comparison for Foresee Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Foresee Biosystems
Foresee Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altis Biosystems, Toxys, ATANIS Biotech, Inovotion and ABL Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of invitro platform for drug testing
|
|
| Locked | Locked | Locked |
In vitro genotoxicity testing services are provided using proprietary technology.
|
|
| Locked | Locked | Locked |
Developer of a cell-based assay for the diagnosis of allergies
|
|
| Locked | Locked | Locked |
Provider of in vivo oncology efficacy and toxicity assays for drug discovery and development
|
|
| Locked | Locked | Locked |
Molecular biology assays and kits are developed for microbiology labs.
|
|
| Locked | Locked | Locked |
Human stem-cell technologies for drug testing and toxicology are provided.
|
Detailed competitors of Foresee Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Foresee Biosystems
Complete news archive for Foresee Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Foresee Biosystems
Foresee Biosystems was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Foresee Biosystems is headquartered in Genoa, Italy. It is registered at Genoa, Liguria, Italy.
Giovanni Melle is the current CEO of Foresee Biosystems.
Foresee Biosystems was founded in 2021 in Genoa, Italy, within the biotechnology sector focused on drug discovery. In vitro Micro Electrode Array (MEA) assays are created using laser technology to assess potential toxicological effects on cellular models. Acute and chronic cardiotoxicity in cardiac cells can be measured through these assays, supporting early-stage toxicity prediction for pharmaceutical development.
Foresee Biosystems's top competitors include Altis Biosystems, ABL Diagnostics and ATANIS Biotech.
Foresee Biosystems offers IntraCell.
Foresee Biosystems has 1 investor. Key investors include European Union.